http://archive.fast-edgar.com/20240423/AGB4W22C8Z22V2Z222JD2WZZ35WOZ2R23262
Filed on: April 23, 2024
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For the month of April 2024
Commission File Number: 001-36622
PROQR THERAPEUTICS N.V.
Zernikedreef 9
2333 CK Leiden
The Netherlands
Tel: +31 88 166 7000
(Address, Including Zip Code, and Telephone Number,
Including Area Code, of... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐
Preliminary Proxy Statement
☐
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☐
Definitive Proxy... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐
Preliminary Proxy Statement
☐
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☐
More SEC Filings
View Older Stories-
Form 8-K KIMBERLY CLARK CORP For: Apr 23
-
Form 8-K Philip Morris Internatio For: Apr 23
-
Form 6-K Mobilicom Ltd For: Apr 23
-
Form DEF 14A Syros Pharmaceuticals, For: Jun 05
-
Form DSTRBRPT International Finance
-
Form 8-K CAMBRIDGE BANCORP For: Apr 23
-
Form DSTRBRPT International Finance
-
Form DEF 14A Cabaletta Bio, Inc. For: Jun 03
-
Form DSTRBRPT International Finance
-
Form 8-K Seres Therapeutics, Inc. For: Apr 19
-
Form 10-Q MANHATTAN BRIDGE CAPITAL For: Mar 31
-
Form 8-K ClearSign Technologies For: Apr 22
-
Form 8-K Theriva Biologics, Inc. For: Apr 23
-
Form 10-Q MBC FUNDING II CORP. For: Mar 31
-
Form 6-K Tiziana Life Sciences For: Apr 23
-
Form 8-K CAMBRIDGE BANCORP For: Apr 23
-
Form 8-K Option Care Health, Inc. For: Apr 23
-
Form 8-K RTX Corp For: Apr 23
-
Form 10-Q BANK OF HAWAII CORP For: Mar 31
-
Form 8-K PENTAIR plc For: Apr 23
-
Form 8-K RYDER SYSTEM INC For: Apr 23
-
Form 8-K MSCI Inc. For: Apr 23
-
Form 1-K Red Oak Capital Fund For: Dec 31
-
Form 8-K QUEST DIAGNOSTICS INC For: Apr 23
-
Form D Emma Grace Healing Hospi
-
Form 6-K GENETIC TECHNOLOGIES For: Apr 23
-
Form 8-K XEROX CORP For: Apr 23 Filed by: Xerox Holdings Corp
-
Form ARS UNIVERSAL HEALTH REALTY For: Dec 31
-
Form 8-K CARDINAL HEALTH INC For: Apr 23
-
Form 6-K GENETIC TECHNOLOGIES For: Apr 23
-
Form DEFA14A UNIVERSAL HEALTH REALTY
-
Form 8-K Aquaron Acquisition Corp For: Apr 19
-
Form 20-F ONECONNECT FINANCIAL For: Dec 31
-
Form D Palumni-SM-0404 Fund I,
-
Form 6-K GENETIC TECHNOLOGIES For: Apr 23
-
Form 6-K Ermenegildo Zegna N.V. For: Apr 23
-
Form 10-Q HERC HOLDINGS INC For: Mar 31
-
Form 1-K Future Cardia, Inc. For: Dec 31
-
Form 8-K HERC HOLDINGS INC For: Apr 23
-
Form DEF 14A UNIVERSAL HEALTH REALTY For: Jun 05
-
Form 8-K JETBLUE AIRWAYS CORP For: Apr 23
-
Form 6-K GENETIC TECHNOLOGIES For: Apr 23
-
Form 6-K Baozun Inc. For: Apr 23
-
Form D MU-0311 Fund II, a serie
-
Form 8-K Flutter Entertainment For: Apr 23
-
Form 20-F Yalla Group Ltd For: Dec 31
-
Form 10-Q GENERAL ELECTRIC CO For: Mar 31
-
Form SC TO-I/A CONX Corp. Filed by: CONX Corp.
-
Form 6-K SMITH & NEPHEW PLC For: Apr 23
-
Form 8-K GENERAL ELECTRIC CO For: Apr 23